Mainz Gross Profit from 2010 to 2025

MYNZ Stock

USD 4.58 0.22 4.58%

Mainz Biomed Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Mainz Biomed BV makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2019-03-31

Previous Quarter

40.3 K

Current Value

319 K

Quarterly Volatility

119.2 K

Covid

Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.2 M or Interest Expense of 977.6 K, as well as many indicators such as Price To Sales Ratio of 919, Dividend Yield of 0.0 or PTB Ratio of 219. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.

Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Mainz Biomed BV over the last few years. Gross profit is a required income statement account that reflects total revenue of Mainz Biomed BV minus its cost of goods sold. It is profit before Mainz Biomed operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Mainz Biomed's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 540.96 K

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Mainz Gross Profit Regression Statistics

	Arithmetic Mean	98,833
	Geometric Mean	111,191
	Coefficient Of Variation	253.71
	Mean Deviation	200,130
	Median	(61,271)
	Standard Deviation	250,751
	Sample Variance	62.9B
	Range	676.7K
	R-Value	0.83
	Mean Square Error	21.3B
	R-Squared	0.68
	Significance	0.000077
	Slope	43,575
	Total Sum of Squares	943.1B

Mainz Gross Profit History

	2025	615.4 K
	2024	586.1 K
	2023	509.7 K
	2022	182.2 K
	2021	177.6 K
	2020	123.1 K

Other Fundumenentals of Mainz Biomed BV

Gross Profit Margin

Mainz Biomed Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Net Tangible Assets	Property Plant Equipment	Intangible Assets
Total Assets		0.9	0.94	-0.73	-0.9	0.84	0.75	0.83	0.77	0.99	0.71	0.97	0.87	0.6	0.72	0.87	0.94	-0.83	-0.4
Total Stockholder Equity	0.9		0.92	-0.94	-0.67	0.62	0.73	0.6	0.51	0.95	0.42	0.98	0.58	0.86	0.44	0.58	0.84	-0.7	-0.27
Current Deferred Revenue	0.94	0.92		-0.8	-0.76	0.73	0.91	0.65	0.63	0.95	0.55	0.95	0.76	0.71	0.57	0.76	0.94	-0.79	-0.31
Net Debt	-0.73	-0.94	-0.8		0.4	-0.32	-0.61	-0.31	-0.19	-0.81	-0.09	-0.87	-0.32	-0.98	-0.11	-0.32	-0.63	0.44	0.0
Retained Earnings	-0.9	-0.67	-0.76	0.4		-0.98	-0.63	-0.97	-0.96	-0.85	-0.94	-0.79	-0.93	-0.22	-0.94	-0.93	-0.91	0.9	0.63
Accounts Payable	0.84	0.62	0.73	-0.32	-0.98		0.65	0.98	0.99	0.79	0.97	0.74	0.9	0.15	0.97	0.9	0.91	-0.96	-0.76
Long Term Debt	0.75	0.73	0.91	-0.61	-0.63	0.65		0.5	0.56	0.74	0.5	0.77	0.64	0.55	0.51	0.64	0.88	-0.77	-0.36
Net Receivables	0.83	0.6	0.65	-0.31	-0.97	0.98	0.5		0.98	0.78	0.96	0.72	0.88	0.12	0.97	0.88	0.84	-0.9	-0.75
Total Liab	0.77	0.51	0.63	-0.19	-0.96	0.99	0.56	0.98		0.71	0.99	0.64	0.89	0.01	1.0	0.89	0.84	-0.92	-0.79
Net Invested Capital	0.99	0.95	0.95	-0.81	-0.85	0.79	0.74	0.78	0.71		0.64	0.99	0.81	0.69	0.65	0.81	0.92	-0.8	-0.36
Short Long Term Debt	0.71	0.42	0.55	-0.09	-0.94	0.97	0.5	0.96	0.99	0.64		0.56	0.87	-0.09	1.0	0.87	0.79	-0.88	-0.79
Total Current Assets	0.97	0.98	0.95	-0.87	-0.79	0.74	0.77	0.72	0.64	0.99	0.56		0.72	0.77	0.58	0.72	0.91	-0.79	-0.35
Capital Stock	0.87	0.58	0.76	-0.32	-0.93	0.9	0.64	0.88	0.89	0.81	0.87	0.72		0.16	0.88	1.0	0.84	-0.81	-0.48
Net Working Capital	0.6	0.86	0.71	-0.98	-0.22	0.15	0.55	0.12	0.01	0.69	-0.09	0.77	0.16		-0.07	0.16	0.5	-0.29	0.13
Short Term Debt	0.72	0.44	0.57	-0.11	-0.94	0.97	0.51	0.97	1.0	0.65	1.0	0.58	0.88	-0.07		0.88	0.8	-0.89	-0.79
Common Stock	0.87	0.58	0.76	-0.32	-0.93	0.9	0.64	0.88	0.89	0.81	0.87	0.72	1.0	0.16	0.88		0.84	-0.81	-0.48
Net Tangible Assets	0.94	0.84	0.94	-0.63	-0.91	0.91	0.88	0.84	0.84	0.92	0.79	0.91	0.84	0.5	0.8	0.84		-0.95	-0.59
Property Plant Equipment	-0.83	-0.7	-0.79	0.44	0.9	-0.96	-0.77	-0.9	-0.92	-0.8	-0.88	-0.79	-0.81	-0.29	-0.89	-0.81	-0.95		0.81
Intangible Assets	-0.4	-0.27	-0.31	0.0	0.63	-0.76	-0.36	-0.75	-0.79	-0.36	-0.79	-0.35	-0.48	0.13	-0.79	-0.48	-0.59	0.81

Click cells to compare fundamentals

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	586.1 K	615.4 K
Gross Profit Margin	0.51	0.54

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC